You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
The mechanism of acute promyelocytic leukemia treatment using the realgar-indigo naturalis formula
- In: D25 What’s new in industry & science? Part 2 on Thursday, 6 September 2018, 10:10 -10:20
- At: Glasgow (Scotland) (2018)
- Type: Presentation
- By: WANG, Xiaobo (Beihai Hoapital, China)
- Co-author(s): Xiaobo Wang:
- Abstract:
Background
Acute promyelocytic leukemia (APL), a M3 subtype of acute myeloid leukemia (AML), has changed from a highly fatal subtype to a curable subtype of leukemia. The widely accepted treatment of APL in China is the combination of retinoic acid (ATRA), small dose of chemotherapy, and arsenic preparations. There are two types of arsenic.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026